Sequoia Financial Advisors’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.52M | Buy |
98,050
+33,451
| +52% | +$517K | 0.01% | 547 |
|
|
2025
Q1 | $961K | Buy |
64,599
+26,656
| +70% | +$396K | 0.01% | 627 |
|
|
2024
Q4 | $502K | Buy |
37,943
+11,637
| +44% | +$154K | ﹤0.01% | 798 |
|
|
2024
Q3 | $374K | Buy |
26,306
+3,318
| +14% | +$47.2K | ﹤0.01% | 867 |
|
|
2024
Q2 | $297K | Buy |
22,988
+592
| +3% | +$7.66K | ﹤0.01% | 893 |
|
|
2024
Q1 | $311K | Buy |
22,396
+2,159
| +11% | +$30K | ﹤0.01% | 843 |
|
|
2023
Q4 | $289K | Sell |
20,237
-4,137
| -17% | -$59K | ﹤0.01% | 946 |
|
|
2023
Q3 | $377K | Buy |
24,374
+1,353
| +6% | +$20.9K | 0.01% | 602 |
|
|
2023
Q2 | $362K | Buy |
23,021
+1,832
| +9% | +$28.8K | 0.01% | 628 |
|
|
2023
Q1 | $349K | Buy |
21,189
+1,692
| +9% | +$27.9K | 0.01% | 574 |
|
|
2022
Q4 | $304K | Buy |
19,497
+7,220
| +59% | +$113K | 0.01% | 575 |
|
|
2022
Q3 | $159K | Buy |
12,277
+2,150
| +21% | +$27.8K | 0.01% | 498 |
|
|
2022
Q2 | $142K | Sell |
10,127
-759
| -7% | -$10.6K | ﹤0.01% | 558 |
|
|
2022
Q1 | $156K | Buy |
+10,886
| New | +$156K | ﹤0.01% | 626 |
|